Polymorphism of the Fractalkine Receptor CX3CR1 and Systemic Sclerosis-associated Pulmonary Arterial Hypertension
Fractalkine (FKN) and its receptor CX3CR1 are critical mediators in the vascular and tissue damage of several chronic diseases, including systemic sclerosis (SSc) and pulmonary arterial hypertension (PAH). Interestingly, the V249I and T280M genetic polymorphism...
Main Authors: | Bianca Marasini, Roberta Cossutta, Carlo Selmi, Maria Rosa Pozzi, Marco Gardinali, Marco Massarotti, Maddalena Erario, Lodovica Battaglioli, Maria Luisa Biondi |
---|---|
Format: | Article |
Language: | English |
Published: |
Hindawi Limited
2005-01-01
|
Series: | Clinical and Developmental Immunology |
Online Access: | http://dx.doi.org/10.1080/17402520500303297 |
Similar Items
-
Modulation of fractalkine receptor (CX3CR1) activation
by: Tan, Thomas Chin Che
Published: (2011) -
Fractalkine/CX3CR1 Pathway in Neuropathic Pain: An Update
by: Rita Silva, et al.
Published: (2021-07-01) -
Fractalkine/CX3CR1 signalling during neuropathic pain
by: Anna K Clark, et al.
Published: (2014-05-01) -
Elevated Expression of Fractalkine (CX3CL1) and Fractalkine Receptor (CX3CR1) in the Dorsal Root Ganglia and Spinal Cord in Experimental Autoimmune Encephalomyelitis: Implications in Multiple Sclerosis-Induced Neuropathic Pain
by: Wenjun Zhu, et al.
Published: (2013-01-01) -
Fractalkine/CX3CL1 in Neoplastic Processes
by: Jan Korbecki, et al.
Published: (2020-05-01)